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Innate cell-autonomous antiviral responses are essential first lines of defense against central nervous system infections but may also contribute to
neuropathogenesis. We investigated the relationships between innate immunity and neuronal differentiation using an in vitro culture system with
human cell lines to analyze cellular responses to the neurotropic alphavirus western equine encephalitis virus. Human neuronal cells displayed a
maturation-dependent reduction in virus-induced cytopathology that was independent of autocrine interferon α or β activity. In addition, maturation
was associated with enhanced responsiveness to exogenous stimuli, such that differentiated neurons required five- to ten-fold less type I interferon to
suppress viral replication or virus-induced cytopathology compared to immature cells, although this enhanced responsiveness extended to only a
subset of unique type I interferons. These results demonstrate that maturation-dependent changes in human neuronal cells may be key determinants in
the innate immune response to infections with neurotropic alphaviruses.
© 2007 Elsevier Inc. All rights reserved.Keywords: Neurons; Differentiation; Alphavirus; InterferonIntroduction
The innate antiviral immune response is a crucial mechanism
to control viral replication prior to the induction of adaptive
immunity (Hoebe et al., 2004). Numerous studies have dem-
onstrated that both mice (Aguilar et al., 2005; Grieder and
Vogel, 1999; Muller et al., 1994; Ryman et al., 2000; van den
Broek et al., 1995) and humans (Casrouge et al., 2006; Dupuis
et al., 2003; Zhang et al., 2007) with deficient type I interferon
(IFN) responses, a prominent component of the innate immune
system (Samuel, 2001), are dramatically more susceptible to
serious and often lethal viral infections. Despite its critical role
in defense against viral infections, the inappropriate activation
of innate immunity in particular cellular microenvironments can
also have catastrophic effects on the host. For example, type I⁎ Corresponding author. Department of Internal Medicine, Division of
Infectious Diseases, 5220E MSRB III, 1150 W. Medical Center Drive, Ann
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doi:10.1016/j.virol.2007.10.025IFN-mediated responses can result in cell death as a method to
control viral replication or dissemination, but this normally
protective response is detrimental when target cells have
essential functions but limited renewal capacity, such as mature
central nervous system (CNS) neurons (Horner andGage, 2000).
Nevertheless, protection and recovery from CNS infections with
neurotropic viruses also depend upon a functional innate
immune system (Aguilar et al., 2005; Grieder and Vogel,
1999; Ryman et al., 2000), suggesting that cell type-specific
responses may be important determinants of viral pathogenesis
(Daffis et al., 2007; Kato et al., 2005; Ma et al., 2006).
To study the interactions between innate immunity and viral
pathogenesis within the CNS we use the neurotropic alphavirus
western equine encephalitis virus (WEEV), a mosquito-borne
enveloped RNA virus that belongs to the Togaviridae family.
The neurotropic alphaviruses, which include WEEV and the
closely related eastern and Venezuelan equine encephalitis
viruses, cause sporadic and epidemic equine and human CNS
infections (Deresiewicz et al., 1997; Earnest et al., 1971). The
virulent neurotropic alphaviruses are also important members of
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threats (Gubler, 2002) and are listed as CDC and NIAID
category B bioterrorism agents due in part to their neuroviru-
lence, dissemination potential, and lack of effective therapies
(Sidwell and Smee, 2003). A detailed understanding of the
host–pathogen interactions that occur within the CNS during
innate immune responses to neurotropic alphavirus infections
may reveal novel targets for the rational design of antiviral
drugs and may also reveal additional genetic determinants that
influence susceptibility to viral neuropathogenesis (Casrouge
et al., 2006; Dupuis et al., 2003; Zhang et al., 2007).
The molecular mechanisms of alphavirus replication and
pathogenesis have been studied extensively with Sindbis virus
(SINV), which in humans causes a systemic infection char-
acterized by fever, rash, and arthritis, whereas in mice it infects
neurons and produces encephalitis (Griffin, 2001). The
alphavirus genome is an 11- to 12-kb single-stranded positive-
sense RNA with a 5′ terminal cap and 3′ polyadenylated tail.
Genomic RNA is translated into a polyprotein that undergoes
regulated autocatalytic processing to form the four nonstructural
replicase proteins (nsPs) 1 through 4. During replication via a
negative-strand genomic intermediate, alphaviruses produce a
4-kb subgenomic RNA that encodes the structural capsid
protein and envelope glycoproteins. SINV infection in most
cultured mammalian cells is accompanied by the rapid in-
hibition of host cell RNA and protein synthesis and eventual
cell death (Gorchakov et al., 2005). In contrast, infection of
mature rodent CNS neurons can lead to a non-cytopathic
persistent infection (Burdeinick-Kerr and Griffin, 2005; Vernon
and Griffin, 2005), similar to the response of infected mosquito
cells in culture (Griffin, 2001).
Despite the substantial amount of information regarding
innate immunity in non-neuronal cells, we have only limited
knowledge regarding the initiation, amplification, and effector
mechanisms of neuron-specific innate antiviral responses. Gene
expression studies have demonstrated the upregulation of
multiple IFN-stimulated genes (ISGs) in response to neurotropic
virus infections or type I IFN stimulation in vitro and in vivo
(Johnston et al., 2001; Labrada et al., 2002; Ousman et al., 2005;
Prehaud et al., 2005) and have suggested that neurons may
respond differently than non-neuronal cells to type I IFNs (Wang
and Campbell, 2005). Furthermore, directed in vivo over-
expression of IFNα in the CNS is neurotoxic despite its
simultaneous role in protecting against lethal neurotropic viral
infections (Akwa et al., 1998). These observations suggest that
CNS neurons may employ distinct mechanisms that balance
innate antiviral responses to both control virus replication and
prevent immune-mediated cellular damage.
In this report we describe the impact of cellular differentiation
on the responses of cultured human neuronal cells to both
infection with WEEV and stimulation with exogenous type I
IFNs. Although neuronal maturity is a well-recognized deter-
minant in the pathogenesis of SINV-induced disease in mice
(Labrada et al., 2002; Lewis et al., 1996; Trgovcich et al., 1999),
the role of neuronal differentiation in cell-autonomous innate
immune responses and type I IFN stimulation remains poorly
defined, particularly in the context of infections with virulentneurotropic alphaviruses such as WEEV. We used three different
human neuronal cell lines and found a direct correlation between
cellular differentiation and partial resistance to WEEV-induced
cytopathology and that maturation-dependent resistance was in-
dependent of autocrine type I IFN activity. Furthermore, neuronal
differentiation also correlated with heightened responses to type I
IFNs, such that five- to ten-fold lower doses were required to
induce an antiviral state, although these enhanced responses
extended to only a subset of type I IFNs. These results suggest that
neuronal maturity is a critical determinant in the cellular response
to virulent neurotropic alphavirus infections in humans and that
the process of neuronal differentiation induces changes that alter
innate immune response pathway activity.
Results
Human BE(2)-C cells differentiated with retinoic acid (RA)
display characteristics of mature neuronal cells and remain
susceptible to WEEV infection
We sought to develop a readily available and reproducible in
vitro culture model to study cellular differentiation and WEEV
pathogenesis in human neurons (Fig. 1). We chose to use the BE
(2)-C neuroblastoma cell line, a clone of SK-N-BE cells that has
phenotypic characteristics of immature neurons (Peverali et al.,
1996), and cultured cells in the presence of 10 μM RA for 3
weeks to induce differentiation. Immature BE(2)-C cells had a
polygonal morphology and grew as a homogeneous monolayer,
whereas RA-differentiated cultures contained primarily cells
with small perikarya and extensive processes that resembled
neuronal axons and dendrites, but also contained a smaller
fraction of flattened cells with larger cell bodies and short
indistinct processes (Fig. 1A). Similar heterogeneous pheno-
types have been described with other RA-differentiated human
neuroblastoma cell lines (Encinas et al., 2000; Hill and
Robertson, 1997) and potentially represent a transdifferentiation
process due to the multipotential nature of neural crest cells
from which most neuroblastomas are thought to arise.
We characterized the BE(2)-C human neuronal culture
system using immunoblotting to examine the expression of
neurofilament (NF) 68, a neuronal lineage lowmolecular weight
intermediate filament protein, and synaptophysin, a synaptic
vesicle protein and a marker of mature differentiated neurons
(Fig. 1B). We detected NF68 expression in both immature and
RA-differentiated BE(2)-C cells but not in control A549 human
lung carcinoma cells, whereas we detected synaptophysin only
in RA-differentiated BE(2)-C cells (Fig. 1B, lane 3). Immuno-
fluorescence analysis confirmed the expression of synaptophy-
sin in vesicle-like structures around the cell periphery and the
filamentous expression of NF200, a high molecular weight
intermediate filament isoform present in mature neurons, in RA-
differentiated but not in immature cells (data not shown). Finally,
we examined the proliferation of immature and RA-differenti-
ated BE(2)-C cells (Fig. 1C). Differentiation with RA for 3
weeks significantly decreased cellular proliferation, such that the
number of differentiated cells increased less than two-fold over
72 h, whereas immature cells increased almost five-fold over the
Fig. 1. Differentiated BE(2)-C human neuroblastoma cells are susceptible to WEEV infection. (A) Light microscopy images of BE(2)-C cells cultured in the absence or
presence of 10 μM RA for 3 weeks. (B) Lysates from an equivalent number of control A549 human lung carcinoma cells (lane 1) or BE(2)-C cells cultured in the
absence (lane 2) or presence (lane 3) of 10 μM RA were immunoblotted for the expression of the neuronal lineage marker NF68, the mature neuronal marker
synaptophysin (Synap), or the loading control glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (C) Proliferation of immature (closed circles) and RA-
differentiated (open circles) BE(2)-C cells. Cell density was measured by MTT assay and is expressed as the fold increase from baseline. Initial experiments
demonstrated a direct correlation between cell number and MTT signal for both immature and differentiated cells (data not shown). (D) Immunofluorescence
microscopy of cells infected with WEEVat an MOI of 10 and processed at 12 hpi. Mock or WEEV-infected immature (upper two rows) or differentiated (lower row)
BE(2)-C cells were immunostained with mouse monoclonal antibodies against WEEV virions (middle column) or rabbit polyclonal antibodies against nsP1 (right
column). The nuclear stain DAPI is shown in the left column. The arrow indicates an infected differentiated BE(2)-C cell with a small perikaryon and extensive
processes characteristic of mature neurons, whereas the arrowhead indicates an infected cell with a larger cell body and shorter processes. (E) Analysis of WEEV nsP
and RNA accumulation in infected cells. Lysates from immature (lanes 1–4) and differentiated (lanes 5–8) BE(2)-C cells infected with WEEVat an MOI of 10 were
prepared at 6, 12, and 24 hpi and analyzed by immunoblotting with polyclonal rabbit antibodies against WEEV nsPs or monoclonal mouse antibodies against GAPDH.
Total RNA from cells described above was analyzed by Northern blotting with a strand-specific 32P-labeled riboprobe that detected both positive-sense WEEV
genomic (g) and subgenomic (sg) RNA. The positions of 28S and 16S rRNA are shown on the left, and the ethidium bromide-stained 28S rRNA band is shown as a
loading control. Note the detection of the abundant 26S subgenomicWEEVRNA by ethidium bromide staining (arrow). (F) InfectiousWEEV production. We infected
an equal number of immature (closed circles) and differentiated (open circles) BE(2)-C cells with WEEV at an MOI of 10, harvested supernatants at 6, 12, 24, and
48 hpi, and measured infectious virus titers by plaque assay on Vero cell monolayers. Plaque assay sensitivity was 102 plaque-forming units/ml.
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measured 3H-thymidine incorporation over 24 h (data not
shown). These results indicated that RA-differentiated BE(2)-C
cells had morphological and biochemical characteristics of
mature human neuronal cells in culture.
To test the susceptibility of BE(2)-C human neuroblastoma
cells to WEEV we generated infectious virions corresponding tostrain Cba 87 and examined infected cells by immunofluores-
cence microscopy (Fig. 1D). After viral infection with a
multiplicity of infection (MOI) of 10, greater than 90% of both
immature and differentiated BE(2)-C cells expressed WEEV
structural proteins (Fig. 1D, middle column) or nsP1 (Fig. 1D,
right column) at 12 h post-infection (hpi). In RA-differentiated
cultures, bothmorphologically distinguishable cells were infected
Fig. 2. Neuronal differentiation correlates with reduced WEEV-induced
cytopathology independent of autocrine IFNα or β activity. (A) Light
microscopy images of immature (upper row) and differentiated (lower row)
BE(2)-C cells infected with WEEV at an MOI of 0.1. Note the appearance of
rounded and pyknotic cells by 12 hpi in immature cells (black arrows), whereas
viable cells with morphological features of mature neurons are present even at
48 hpi in differentiated BE(2)-C cells (white arrow). (B) Cell viability in
immature (closed symbols) and differentiated (open symbols) BE(2)-C, SH-
SY5Y, and NT-2 cells infected with WEEVat an MOI of 0.1 was quantitated by
MTTassay. Similar results were obtained with BE(2)-C cells using anMOI of 10
(data not shown). Results were normalized to uninfected control cell viability
(⁎pb0.005; ⁎⁎pb0.000005 compared to immature cells). (C) Immature (left
graph) and differentiated (right graph) BE(2)-C cells were treated with 20 U/ml
IFNα or 10 U/ml IFNβ in the presence of 200 U/ml neutralizing antisera against
human IFNα, IFNβ, or 5 μM JAK inhibitor, infected with WEEVat an MOI of
0.1, and viability was determined byMTTassay at 48 or 72 hpi for immature and
differentiated cells, respectively. JAK inhibitor results are shown only for
differentiated BE(2)-C cells, although we obtained similar results with immature
cells (data not shown). Results were normalized to uninfected control cell
viability, and the hatched lines indicate the percent viability of infected cells
treated with control normal rabbit serum.
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accumulation in cells up to 24 hpi by Western and Northern
blotting, respectively (Fig. 1E). WEEV nsP accumulation was
evident in both immature and differentiated cells by 6 hpi and
corresponded to the appearance of detectable viral genomic and
subgenomic RNA (Fig. 1E, lanes 2 and 6). There were no
maturation-dependent differences in the maximal accumulation
levels of viral nsPs or RNA, although their temporal appearance
was slightly delayed in differentiated cells. We obtained similar
results with the prototypic Fleming strain of WEEV (data not
shown).
We further examined WEEV infection in immature and
differentiated BE(2)-C cells by analyzing infectious virion
production in a single-step growth assay (Fig. 1F). Virion
production after infection with an MOI of 10 plateaued around
12 to 24 hpi in both cell types with maximal titers of ap-
proximately 2×105 plaque-forming units per milliliter. Al-
though there was a difference in infectious virion production at
48 hpi between immature and differentiated cells, this
observation likely reflected the significant differences in cell
viability at this late stage after infection (see Fig. 2). Infections
with an MOI of 0.1 produced a slight kinetic delay in virion
production but no significant change in maximal titers at 24 hpi
and did not result in a difference between immature and
differentiated BE(2)-C cells (data not shown). We obtained
similar results with the Fleming strain of WEEV, although
maximal virus titers at 24 hpi were approximately 30-fold
higher (data not shown). These results indicated that BE(2)-C
cells were highly susceptible to WEEV infections and suggested
that neuronal differentiation did not significantly alter WEEV
susceptibility and viral replication during the first 24 h after
infection.
Differentiation of human neuronal cells reduces sensitivity to
WEEV-induced cytopathology independent of autocrine IFNα
or β activity
We initially investigated whether human neuronal cells
showed maturation-dependent cellular responses to WEEV
infection by examining virus-induced cytopathic effect (CPE)
(Fig. 2). Despite the similar levels of virion production and viral
nsP or RNA accumulation between immature and differentiated
BE(2)-C cells during the first 24 hpi (Figs. 1E and F), neuronal
maturation had a significant impact on the cellular response to
virus infection. WEEV-induced CPE was visually evident in
immature BE(2)-C cells by 12 hpi and was characterized by the
appearance of rounded and pyknotic cells (Fig. 2A, upper left
image). Significant CPE had developed in immature cells by
24 hpi, and essentially no viable-appearing cells remained at
48 hpi (Fig. 2A, upper right image). In contrast, although CPE
was evident in differentiated cells after WEEV infection, the
intensity of the response was reduced such that viable cells were
still visible at 48 hpi (Fig. 2A, lower right image). When we
quantitated cell viability after virus infection by 3-[4,5-
dimethylthizol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
assay, there was a significant decrease in virus-induced CPE in
differentiated compared to immature cells up to 96 hpi (Fig. 2B,
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(2)-C cells was unable to completely abrogate WEEV-mediated
CPE as cell viability at 120 hpi was less than 10% with both cell
types, these results indicated that human neuronal cell
maturation in vitro was accompanied by an increased resistance
to WEEV-induced CPE.
The culture conditions that we used to differentiate BE(2)-2
cells allowed us to directly compare immature and mature
neuronal cells grown in similar serum-containing media, with
the notable exception of RA. However, RA-differentiated BE
(2)-C cultures were not morphologically homogeneous and
failed to completely exit the cycle (see Figs. 1A and C), and thus
we also used an alternative differentiation protocol that involved
a shortened exposure to RA and subsequent treatment with
brain-derived neurotropic growth factor (BDNF). This approach
has been used with other human neuroblastoma cells to produce
BDNF-dependent mature neuronal cells that are post-mitotic
but remain viable and functional in RA- and serum-free media
(Encinas et al., 2000). We were similarly able to generate
morphologically homogenous and non-proliferating cultures with
BE(2)-C cells using a sequential RA-BDNF protocol (data not
shown). These cultures also showed reduced sensitivity to
WEEV-induced CPE with 78% viability at 48 hpi. Although the
culture conditions used to produce BDNF-dependent differenti-
ated BE(2)-C cells did not allow us to have a directly comparable
immature cell population, these results were consistent with those
obtained using RA-only differentiated cells (Fig. 2B, left graph),
suggesting that culture heterogeneity or differentiation con-
ditions did not have a significant impact on the maturation-
dependent cytopathic responses of BE(2)-C cells to WEEV
infection.
Although immortalized cell lines are commonly used as tools
to investigate viral pathogenesis, individual transformed cell
lines may display aberrant phenotypes. Thus, to further examine
the impact of human neuronal maturation on WEEV-induced
CPE we analyzed cell viability after virus infection of immature
and differentiated cells using two additional independently
derived human cell lines (Fig. 2B, right graph). The SH-SY5Y
cell line is a human neuroblastoma that also differentiates into
cells with a mature neuronal phenotype in response to RA
treatment (Encinas et al., 2000), whereas the NT-2 cell line is a
human embryonal carcinoma that differentiates into mature
neuronal cells in response to RA, mitotic inhibitors, and
selective plating conditions (Pleasure et al., 1992). Differenti-
ated SH-SY5Y and NT-2 cells both displayed phenotypes
consistent with mature neuronal cells, including the presence of
multiple processes reminiscent of axons and dendrites,
expression of mature neuronal markers, and the absence of
proliferation over 72 h (data not shown). When we examined
cellular responses to WEEV infection, both differentiated SH-
SY5Y and NT-2 cells showed a significant reduction in virus-
induced CPE compared to immature cells (Fig. 2B, right graph),
similar to results with differentiated BE(2)-C cells (Fig. 2B, left
graph), strengthening the conclusion that a direct correlation
existed between human neuronal maturity and partial but not
complete resistance to virulent neurotropic alphavirus-induced
cytopathology.Autocrine or paracrine type I IFN-mediated amplification of
innate immune responses is an important component of non-
neuronal cellular responses to virus infection (Samuel, 2001).
One hypothesis to explain the maturation-dependent responses
of cultured human neuronal cells to WEEV infection is that RA-
induced differentiation modulated type I IFN-mediated auto-
crine activity. Although neurons are generally not considered to
be primary producers of type I IFNs during innate immune
responses, differentiated human neuronal cells can produce
IFNβ in culture (Prehaud et al., 2005), and in vivo data suggest
that rodent CNS neurons can also produce type I IFNs during
viral encephalitis (Delhaye et al., 2006). We initially examined
IFNα and β levels in supernatants of cultured immature and
differentiated BE(2)-C cells after WEEV infection by both
bioassays and commercially available ELISAs but were unable
to detect appreciable levels of either type I IFN (data not shown).
We subsequently used antibody neutralization experiments to
examine the presence of functional type I IFNs secreted after
WEEVinfection (Fig. 2C). Immature and differentiated BE(2)-C
cells were infected with WEEV at an MOI of 0.1 and si-
multaneously treated with neutralizing antiserum against human
IFNα, IFNβ, or control normal rabbit serum. As positive
controls, we treated infected cells with either purified recombi-
nant human IFNα or β in combination with a 10- to 20-fold
excess of neutralizing antiserum. We measured viability at 48
and 72 hpi for immature and differentiated cells, respectively, to
ensure that baseline viability in the absence of treatment was
approximately 30% (see Fig. 2B, left graph). Control samples
treated with either exogenous IFNα or β in the absence of the
appropriate neutralizing antibody showed a significant reduction
inWEEV-induced CPE with both immature (Fig. 2C, left graph)
and differentiated (Fig. 2C, right graph) BE(2)-C cells, which
was reversed in the presence of the appropriate neutralizing
antibody. However, in the absence of exogenous IFNα or β
neither antiserum had a significant impact on WEEV-induced
CPE irrespective of cellular maturation. In particular, differen-
tiated BE(2)-C cells showed no decrease in viability with IFNα
or β neutralization after WEEV infection (Fig. 2C, right graph).
Furthermore, treatment of differentiated BE(2)-C cells with a
cell-permeable inhibitor of Janus tyrosine kinases (JAKs), which
are essential components of the type I IFN-mediated signaling
cascade (Schindler et al., 2007), had minimal effect on WEEV-
induced CPE in the absence of exogenous type I IFNs (Fig. 2C,
right graph). These results suggested that autocrine activity of
IFNα or β played a minor if any role in the neuronal maturation-
dependent responses of BE(2)-C cells to WEEV infection.
However, the results with control IFNα or β also indicated that
both immature and differentiated BE(2)-C human neuronal cells
could respond to exogenous type I IFNs and activate cellular
pathways that reduced WEEV-induced CPE.
Differentiated human neuronal cells display a
heightened response to exogenous type I IFN stimulation
We further examined the effects of exogenous type I IFNs on
WEEVinfection inBE(2)-C cells using IFNα-A/D, a recombinant
hybrid universal type I IFN (Fig. 3). Although type I IFNs have
Fig. 3. Type I IFNs suppress WEEV-induced CPE and virion production in
human neuronal cells. (A) WEEV-induced CPE. Immature (left graph) and
differentiated (right graph) BE(2)-C cells were either pretreated (pre-Rx) with
50 U/ml IFNα-A/D for 24 h and infected with WEEV at an MOI of 0.1, or
treated with a single 50 U/ml IFNα-A/D dose immediately after virion
attachment (co-Rx), and cell viability was determined at 48 and 72 hpi by MTT
assay. Results were normalized to uninfected control cell viability. (B) In-
fectious virion production. Immature (left graph) and differentiated (right
graph) BE(2)-C cells were pretreated with 50 U/ml IFNα-A/D for 24 h, infected
with WEEVat an MOI of 10 or 0.1, and virus titers were determined in culture
supernatants at 24 and 48 hpi by plaque assay on Vero cell monolayers. The
data from untreated cells represent combined results from both high (10) and
low (0.1) MOI infections as there was no significant effect of viral inoculum at
24 or 48 hpi (data not shown) (⁎pb0.05; ⁎⁎pb0.0005 compared to untreated
cells).
Fig. 4. Neuronal differentiation is associated with enhanced responsiveness to
type I IFN stimulation. Immature and differentiated BE(2)-C cells were
pretreated with decreasing concentrations of IFNα-A/D for 24 h, infected with
WEEV at an MOI of 0.1, and samples were analyzed at 24 hpi for WEEV nsP
(A) and RNA (B) accumulation by immunoblotting and Northern blotting,
respectively, as described in Fig. 1. (C) Dose response of immature (closed
circles) or differentiated (open circles) BE(2)-C cells stably transfected with
pISRE-SEAP. Reporter gene activity was measured at 24 h after IFNα-A/D
stimulation. Calculated concentrations that produced a 50% maximal response
in reporter gene activity (EC50) are shown (⁎pb0.01 compared to immature BE
(2)-C cells).
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malignant cell lines, treatment of immature or differentiated BE
(2)-C cells with 50 U/ml IFNα-A/D for 72 h resulted in 94% and
97% viability compared to untreated cells, respectively, and
titration studies indicated that concentrations up to 500 U/ml had
minimal impact on cell viability (data not shown). However,
IFNα-A/D significantly reducedWEEV-induced CPE at 48 hpi in
both immature and differentiated cells (Fig. 3A). This reduction in
CPE was evident irrespective of whether cells were pretreated for
24 h prior to infection with an MOI of 0.1 or given a single 50 U/
ml dose of IFNα-A/D at the time of infection, although immature
cells showed an attenuated response to the pretreatment compared
to co-treatment strategy. Furthermore, only the co-treatment
strategy effectively suppressed WEEV-induced CPE in immature
BE(2)-C cells when we measured viability at 72 hpi (Fig. 3A, leftgraph), whereas both treatment strategies were equally effective in
differentiated cells (Fig. 3A, right graph). We obtained similar
results when we used both a higher inoculum (MOI=10) or the
Fleming strain of WEEV (data not shown). We also examined the
suppressive activity of IFNα-A/D in WEEV-infected BE(2)-C
cells by analyzing infectious virion production (Fig. 3B). Re-
gardless of the initial inoculum, pretreatment with IFNα-A/D
suppressed infectious WEEV production at 24 hpi by approxi-
mately 100-fold in both immature and differentiated cells. How-
ever, the protective effects of IFNα-A/D pretreatment on
infectious virus production diminished in immature cells by
48 hpi (Fig. 3B, left graph), whereas virus titers were still sup-
pressed by greater than 10-fold at this time point in differentiated
cells (Fig. 3B, right graph). These results indicated that BE(2)-C
human neuronal cells responded to exogenous type I IFNs to
activate cell-autonomous antiviral responses that reduced virion
production and prevented WEEV-induced CPE. Furthermore,
Table 1
IFNα-A/D IC50 values with WEEV-infected immature and differentiated human
neuronal cells
Cell line Parameter a IFNα-A/D IC50 (U/ml)
b
Immature Differentiated
BE(2)-C Viability c 75±8 6±1
Virion production 59±10 7±5
Viral nsP accumulation d 28±7 3±1
Viral RNA accumulation e 56±13 12±5
SH-SY5Y Viability 156±7 17±3
NT-2 Viability N250 15±1
a We determined virion production, viral nsP, and viral RNA accumulation
values at 24 hpi. The time point for viability determination corresponded to
approximately 30 to 40% viability in the absence of IFNα-A/D, which was
48 hpi for immature NT-2 and BE(2)-C cells, 48 and 72 hpi for immature SH-
SY5Y cells, 72 hpi for differentiated BE(2)-C cells, and 72 and 96 hpi for
differentiated SH-SY5Y and NT-2 cells.
b Results represent the mean±SEM from three independent experiments
except viability values in differentiated NT-2 cells, which were obtained from
two independent experiments.
c Viability IC50 values for immature and differentiated BE(2)-C cells
corresponded to 750 and 60 pg/ml, respectively, based on the IFNα-A/D
specific activity of 108 U/mg listed by the manufacturer as determined by
antiviral effects against vesicular stomatitis virus in Madin-Darby bovine kidney
cells.
d Total nsP1 and 3 accumulation assessed by immunoblotting (see Fig. 4A).
e Genomic and subgenomic RNA accumulation assessed by Northern blotting
(see Fig. 4B).
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responses in part by prolonging their activity after type I IFN
stimulation.
To further investigate the impact of neuronal differentiation
on type I IFN responsiveness we conducted dose-titration ex-
periments (Fig. 4). Cells were pretreated for 24 h with
decreasing concentrations of IFNα-A/D, infected with WEEV
at an MOI of 0.1, and viral nsP (Fig. 4A) and RNA (Fig. 4B)
levels were analyzed at 24 hpi by quantitative immunoblotting
and Northern blotting, respectively. Both immature and
differentiated BE(2)-C cells showed dose-dependent responses
to IFNα-A/D that resulted in the suppression of WEEV nsP and
RNA accumulation. However, RA-induced neuronal differen-
tiation resulted in significantly increased sensitivity to type I
IFN stimulation. We calculated the IFNα-A/D doses that
produced 50% inhibition (IC50) of WEEV-induced CPE, virion
production, and viral nsP and RNA accumulation in both
immature and differentiated cells (Table 1). Differentiated BE
(2)-C cells had five- to ten-fold lower IC50 values for all
parameters compared to immature cells. We also conducted
limited dose-titration experiments with BDNF-dependent ma-
ture BE(2)-C cells and obtained an IC50 of approximately 5 U/ml
for reduction in WEEV-induced CPE, similar to the dose
required for RA-only differentiated BE(2)-C cells (Table 1).
Furthermore, we conducted dose-titration experiments with
immature and differentiated SH-SY5Yand NT-2 cells and found
that both cell lines also displayed maturation-dependent en-
hancement of type I IFN responses, such that IC50 values for
reduction in WEEV-induced CPE were approximately ten- to
twenty-fold lower in differentiated compared to immature cells
(Table 1). These results indicated that cellular differentiation hada significant impact on type I IFN responsiveness to produce
enhanced antiviral activity in cultured human neuronal cells.
To initially investigate the underlying mechanisms respon-
sible for the maturation-dependent enhancement of neuronal
type I IFN stimulation from receptor engagement to ISG
upregulation in BE(2)-C cells, we used a secreted alkaline
phosphatase (SEAP) reporter gene linked to a minimal ISG
promoter element (Fig. 4C). To avoid the potential confounding
effects of cellular differentiation on transfection efficiency, we
generated BE(2)-C cells stably transfected with the reporter
plasmid and subsequently induced differentiation with RA. Both
immature and differentiated BE(2)-C cells with an integrated
type I IFN-responsive reporter gene displayed dose-dependent
SEAP expression in response to IFNα-A/D stimulation.
However, the IFNα-A/D concentration that produced a 50%
maximal response differed by four-fold between immature and
differentiated cells (Fig. 4C). Furthermore, the shapes of the
titration curves differed substantially such that the calculated
Hill slopes for immature and differentiated BE(2)-C cells were
1.55 and 0.57, respectively (pb0.05). Similar results were
obtained with immature and differentiated SH-SY5Y cells that
stably expressed the IFN-responsive SEAP reporter gene (data
not shown). These results indicated that neuronal differentiation
enhanced type I IFN signaling pathway activation and ISG
promoter stimulation.
Although type I IFNs are frequently treated as a single entity,
the human genome contains numerous type I IFN families
including 13 α genes encoding 12 distinct subtypes, and single
β, ε, κ,ω, and ν genes (Pestka et al., 2004). The α,β, andω type
I IFNs are the best studied and all exert their effects through a
common cell surface receptor, although different potencies of
distinct type I IFNs with respect to antiviral activity have been
described (Foster et al., 1996; Heim et al., 1996; Sperber et al.,
1992, 1993). To further examine the maturation-dependent
responses of BE(2)-C cells to type I IFN stimulation and WEEV
infection we used a series of purified recombinant type I IFNs
(Table 2). Cells were treated with decreasing concentrations of
individual type I IFNs for 24 h, infected with WEEVat an MOI
of 0.1, and cell viability was measured at 48 and 72 hpi for
immature and differentiated cells, respectively. We subsequently
calculated weight-based IC50 values to eliminate the confound-
ing effects of the different virus–cell combinations used to
determine individual type I IFN specific activities. Several type I
IFNs, in particular IFNα8, IFNα10, and IFNβ, showed potent
antiviral activity in both immature and differentiated cells
infected with WEEV, consistent with previous reports on the
preferential antiviral activity of these type I IFNs against
picornaviruses (Foster et al., 1996; Heim et al., 1996; Sperber
et al., 1993). However, differentiated BE(2)-C cells also showed
enhanced responses to several specific type I IFNs, with
differences ranging from two- to five-fold for IFNα2a, α8,
α14, α16, and IFNω compared to immature cells (Table 2). In
addition, not all type I IFNs showed neuronal maturation-
dependent differential effects. For example, IC50 values for
IFNα5, α6, α10, α17, α21, and IFNβ did not differ significantly
between immature and differentiated cells. We were unable to
determine the significance of potential differences with IFNα1,
Table 2
Differential effects of type I IFNs on resistance to WEEV-induced
cytopathology in immature and differentiated BE(2)-C human neuronal cells
Type I IFN a IC50 (pg/ml)
b
Immature Differentiated
IFNα1 (αD) N1000 N1000
IFNα2a (αA) 812±114 368±77 ⁎
IFNα4 (α4b) N1000 623±179
IFNα5 (αG) 782±86 964±25
IFNα6 (αK) 589±119 649±213
IFNα7 (αJ1) N1000 910±81
IFNα8 (αB2) 151±5 57±28⁎
IFNα10 (αC) 230±36 116±36
IFNα14 (αH2) 830±31 344±79⁎
IFNα16 (αWA) 732±67 239±66⁎
IFNα17 (αI) 639±209 428±144
IFNα21 (αAF) 912±51 789±211
IFNβ 349±85 177±24
IFNω N1000 210±125
a Alternative IFNα subtype designations are given in parentheses. All type I
IFNs were purified recombinant proteins produced in E. coli except IFN-β,
which was produced in mammalian cells.
b Values represent weight-based concentrations that inhibited WEEV-induced
cytopathology by 50% at 48 and 72 hpi for immature and differentiated BE(2)-C
cells, respectively. Results represent the mean±SEM from three independent
experiments. Specific activities listed by the manufacturer, as determined by
antiviral effects against vesicular stomatitis virus in Madin-Darby bovine kidney
cells (IFNα subtypes), vesicular stomatitis virus in Vero cells (IFNβ), or
encephalomyocarditis virus in A549 cells (IFNω), were between 1 and
4×108 U/mg for all type I IFNs except IFN-α1 (7.5×107 U/mg) and IFN-α21
(6.3×108 U/mg). Similar differences between immature and differentiated BE
(2)-C cells were obtained when we used specific activity measurements to
calculate IC50 values with IFNα subtypes.
⁎ pb0.05 compared to immature cells. Indeterminate values above the range
of the assay (N1000 pg/ml) were not subjected to statistical analyses.
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dose of 1000 pg/ml for immature cells and the IC50 values for
differentiated cells were greater than 500 pg/ml. Nevertheless,
these results were consistent with the conclusion that neuronal
maturation influenced type I IFN responsiveness, but indicated
that this differential responsiveness did not apply to all type I
IFNs.
Discussion
In this study we examined the impact of cellular differenti-
ation on WEEV infection and type I IFN responses in cultured
human neuronal cells. We drew four main conclusions. First,
human neuronal cells, and in particular immature and differen-
tiated BE(2)-C neuroblastoma cells, were highly permissive to
WEEV infection, and RA-induced cellular differentiation did
not alter that permissiveness. Second, neuronal differentiation
correlated with increased partial resistance to WEEV-induced
cytopathology, which was independent of autocrine IFNα or
β activity. Third, differentiated neuronal cells displayed a
heightened antiviral response to exogenous type I IFNs, which
was associated with enhanced ISG promoter activation. Fourth,
human neuronal cells showed preferential responsiveness to
distinct type I IFNs in the activation of cellular antiviral
pathways. These results identify maturation-dependent compo-nents of the cell-autonomous innate immune responses utilized
by human neuronal cells to combat infections with virulent
neurotropic alphaviruses.
The limited availability and unreliability of primary human
CNS neuronal cultures prompted us to use immature and
differentiated human cell lines as model systems to examine
cellular innate immune responses. The ability of RA to induce
human neuroblastoma differentiation in culture has been
recognized for decades and is frequently used in neurobiology
to study cellular maturation and physiology in vitro (Encinas
et al., 2000; Hill and Robertson, 1997; Peverali et al., 1996).
Retinoids have been used successfully as adjuvant treatment for
neuroblastomas in children (Matthay et al., 1999), and studies
have shown that they are also important for both normal
embryonic (Sockanathan and Jessell, 1998) and adult (Jacobs
et al., 2006) neuronal development in vivo, indicating that RA-
induced differentiation in culture is a viable approach to study
viral pathogenesis in the context of neuronal maturation.
Nevertheless, the use of RA to induce cellular differentiation
in human neuroblastoma cells as a model culture system is not
without potential drawbacks. For example, although the primary
approach with BE(2)-C cells described in this report allowed us
to directly compare immature and differentiated neuronal cell
populations grown in similar conditions with serum-containing
culture media, RA-differentiated cultures were not morpholog-
ically homogeneous (Figs. 1 and 2). However, we obtained
similar results with respect to resistance to WEEV-induced CPE
and type I IFN responsiveness with homogenous BDNF-
dependent differentiated BE(2)-C cells. Furthermore, the
demonstration of neuronal maturation-dependent responses
with both SH-SY5Y and NT-2 cells (Fig. 2 and Table 1), two
human cell lines unrelated to BE(2)-C cells, supports the
hypothesis that enhanced innate immune responses are associated
with normal human neuronal development and differentiation.
Definitive evidence to support this hypothesis awaits a reliable
and defined culture system to examine neuronal differentiation in
non-malignant human cells. Recent advances in human embry-
onic stem cell technology (Wu et al., 2007) may provide an
alternative and potentially vital approach to investigate the
underlying mechanisms of maturation-dependent and cell-
specific innate immune responses to neurotropic viruses.
The results with WEEV infection of immature and differen-
tiated human neuronal cells in culture shared some similarities
with rodent neuronal culture systems that were developed to
examine SINV neuropathogenesis (Burdeinick-Kerr and Grif-
fin, 2005; Vernon and Griffin, 2005), but there were also
significant differences. Differentiated rat CSM14.1 cells (Zhong
et al., 1993) are less susceptible to SINV-induced cytopathology
(Vernon and Griffin, 2005), consistent with our results using
differentiated human neuronal cells (Fig. 2). However, differ-
entiated rodent neurons demonstrate little CPE up to 6 days after
SINV infection (Vernon and Griffin, 2005), whereas differen-
tiated human neuronal cells, although more resistant than
immature cells, still developed significant CPE in response to
WEEV infection after 4 to 5 days (Fig. 2). Furthermore, dif-
ferentiated CSM14.1 cells are resistant to SINV infection and
incompletely differentiated mouse NSC34 cells (Cashman et al.,
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Kerr and Griffin, 2005; Vernon and Griffin, 2005), whereas we
found no significant differences between immature and
differentiated BE(2)-C cells in the susceptibility to WEEV
infection and replication (Fig. 1). These discrepant observations
may be due to host differences in the intrinsic neuronal antiviral
responses between cultured rodent and human neurons or
secondary to differential alphavirus virulence as the 633 strain of
SINVused in the rodent culture system is avirulent in adult mice
(Tucker et al., 1993), whereas the Cba 87 strain ofWEEVused in
this report is highly virulent in adult animals (Schoepp et al.,
2002). The rodent neuronal culture system has also been used to
demonstrate the important role of IFNγ in noncytolytic
cytokine-mediated clearance of SINV (Burdeinick-Kerr and
Griffin, 2005). Although we did not examine the effects of IFNγ
with the human neuronal cell culture systems described in this
report, prolonged treatment with IFNα-A/D did not completely
eliminate WEEV-induced CPE in differentiated BE(2)-C cells
(data not shown), suggesting that type I IFNs are insufficient to
completely control virus replication and that type II IFNs or
other innate or adaptive immune system components are
required for clearance of WEEV from infected human neuronal
cells.
The underlying molecular mechanisms that impart a
decreased sensitivity of differentiated human neuronal cells to
WEEV-induced CPE are unknown. For rodent neurons, cellular
differentiation is accompanied by an increase in the resistance to
SINV-induced suppression of cellular translation (Vernon and
Griffin, 2005), a prominent component of the cellular response
that ultimately results in cell death in some mammalian cell
lines (Gorchakov et al., 2005). In contrast to rodent cells, we
saw no differences in WEEV-induced suppression of cellular
translation between immature and differentiated BE(2)-C cells
up to 12 hpi (data not shown). Results with BE(2)-C cells also
suggested that autocrine type I IFN activity was not involved in
the intrinsic neuronal maturation-dependent responses to
WEEV infection, as we were unable to detect the secretion of
functional IFNα or β after viral infection (Fig. 2). The absence
of type I IFN production by BE(2)-C cells after WEEV infection
was in contrast to published results demonstrating the
production of IFNβ by differentiated NT-2 cells after rabies
virus infection (Prehaud et al., 2005). However, in addition to
the difference in cell lines, the level of IFNβ produced by rabies
virus-infected NT-2 cells was below the detection sensitivity of
our assays. Furthermore, differentiated NT-2 cells did not
produce IFNβ after herpes simplex virus infection (Prehaud
et al., 2005), suggesting that neuronal type I IFN production
may be virus specific.
We hypothesize that changes in the activation and potenti-
ation of type I IFN-independent innate immune pathways play
an important role in the maturation-dependent responses that
ultimately result in enhanced survival after neurotropic alpha-
virus infection of differentiated neuronal cells. Furthermore, we
hypothesize that these maturation-dependent responses are not
restricted to alphaviruses, as we have also seen reduced CPE in
differentiated BE(2)-C cells infected with either vesicular
stomatitis virus (Rhabdoviridae) or La Crosse virus (Bunyavir-idae) (J. Farmer and D. Miller, unpublished data). In support of
the innate immune pathway hypothesis, preliminary experi-
ments have demonstrated that differentiated BE(2)-C cells show
enhanced innate immune system activation in response to stim-
ulation with the double-stranded RNA mimetic polyinosinic–
polycytidylic acid (D. Peltier and D. Miller, unpublished data).
On the basis of our differentiation protocol, one potential innate
immune system component that may be involved in this altered
responsiveness is the cytosolic pattern recognition receptor
retinoic acid-induced gene I (RIG-I) (Yoneyama et al., 2004),
which was so named due to its upregulation in promyelocytic
leukemia cells during RA-induced differentiation (Liu et al.,
2000). However, we did not identify a significant effect of
prolonged RA stimulation on basal RIG-I expression levels in
BE(2)-C cells (data not shown), suggesting that RA may have
differential stimulatory effects on leukemia and neuroblastoma
cells. Experiments are currently in progress using both targeted
and global genetic profiling studies to identify candidate innate
immune system components whose expression is altered during
human neuronal cell differentiation.
In addition to the maturation-dependent but type I IFN-
independent responses associated with increased survival after
WEEV infection, our studies uncovered a heightened respon-
siveness of differentiated human neuronal cells to exogenous type
I IFNs (Figs. 3 and 4, Tables 1 and 2). This observation suggests
that in themature CNS amaximal antiviral response is obtained in
neuronal cells with exposure to minimal amounts of type I IFNs,
and perhaps other cytokines, thereby reducing the potential for
immune-mediated damage due to excessive inflammation (Akwa
et al., 1998). Furthermore, the observation of the differential
responsiveness of human neuronal cells to distinct type I IFNs
(Table 2) suggests that targeted type I IFN production may also
play an important yet unrecognized role in the overall innate
immune response to neurotropic virus infections within the CNS.
We are currently examining the underlying mechanisms respon-
sible for the increased responsiveness of differentiated human
neuronal cells to type I IFN stimulation. The significant dif-
ferences in the Hill slopes between immature and differentiated
BE(2)-C cells expressing a type I IFN-responsive reporter gene
(Fig. 4C) suggest that alterations in protein–protein interactions,
such as receptor subunit modulation, may be involved. Additional
detailed studies will further define the impact of neuronal
differentiation on individual steps, from receptor engagement to
specific ISG upregulation, in the type I IFN-mediated amplifica-
tion of innate immune responses in the CNS.
Materials and methods
Cell culture and neuronal differentiation
We obtained the human BE(2)-C and SH-SY5Y neuroblas-
tomas, human NT-2 embryonal carcinoma, and African green
monkey kidney Vero cells from the American Type Culture
Collection (Manassas, VA). We cultured BE(2)-C and Vero cells
at 37 °C in a humidified atmosphere with 5% CO2 in high
glucose (4.5 g/l) formulation Dulbecco's modified Eagle's
medium (DMEM) supplemented with 4 mM L-glutamine, 10
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growth serum (HyClone, Logan, UT) (complete DMEM). We
cultured SH-SY5Y cells in RPMI-1640 media supplemented
with 10% bovine growth serum and the antibiotics listed above,
and we maintained undifferentiated NT-2 cells in DMEM with
10% fetal bovine serum.
We routinely differentiated BE(2)-C cells according to
established procedures (Peverali et al., 1996). Briefly, we
added 10 μM all-trans RA to complete DMEM and changed
culture media three times weekly for 3 weeks until cell pro-
liferation slowed and cells developed a morphology consistent
with mature neuronal cells (see Fig. 1). We routinely passed BE
(2)-C cells two to three times by trypsinization during the
differentiation period and plated cells into their final tissue
culture vessels at least 48 h prior to initiating infection or
treatment experiments. To facilitate a direct comparison between
cell types, we used the measured proliferative capacity of
immature and differentiated BE(2)-C cells (see Fig. 1C) to obtain
equal cell densities of 105 cells/ml at either the time of infection
or treatment with type I IFNs. This cell density resulted in a
surface area confluence of approximate 50–80% for both cell
types. For growth factor-dependent differentiation of BE(2)-C
cells, we cultured cells in the presence of 10 μMRA in complete
DMEM for 5 days followed by serum-free DMEM with 50 ng/
ml BDNFwithout RA for an additional 7 days.We differentiated
SH-SY5Y cells with 10 μM RA for 1 week as previously
described (Encinas et al., 2000) and differentiated NT-2 cells
using the 6 week RA-mitotic inhibitor sequential regimen as
previously described (Pleasure et al., 1992).
Viruses
Michael Parker at the U.S. Army Medical Research Institute
of Infectious Diseases generously provided the full-length
WEEV cDNA clone pWE2000 (Schoepp et al., 2002), which
was derived from the WEEV strain Cba 87, an epizootic strain
from Argentina that is both neurovirulent and neuroinvasive in
mice (Bianchi et al., 1993) and cynomolgus macaques (Reed
et al., 2005). To generate infectious virions we transfected Vero
cells with T7 RNA polymerase-synthesized transcripts generat-
ed in vitro from NotI-linearized pWE2000, and 48 h after
transfection harvested tissue culture supernatants and further
expanded virus stocks by two passages in Vero cells at a low
MOI to minimize the formation of defective interfering particles.
The final virus stock titer was 5×106 plaque-forming units/ml as
quantitated by plaque assay on Vero cell monolayers. We also
obtained the prototypic North American Fleming strain of
WEEV from the CDC (Arbovirus Diseases Branch, Fort Collins,
CO) and generated virus stocks in Vero cells that had titers
approximately ten-fold higher than pWE2000-derived virus. We
used pWE2000-derived infectious virus corresponding to strain
Cba 87 for all experiments unless otherwise noted.
Antibodies
To generate polyclonal rabbit antisera against individual
WEEV nsPs we expressed full-length nsP1 and nsP3 and thecarboxy terminal fragment of nsP2 in E. coli, separated partially
purified inclusion bodies by SDS–PAGE, and immunized
rabbits with pulverized gel slices (Harlan Bioproducts for
Sciences, Inc., Madison, WI). We tested rabbit antisera for
reactivity and specificity by immunoblotting with lysates from
mock and WEEV-infected Vero cells (data not shown). We
purified nsP-specific rabbit immunoglobulin from antisera by
Staphylococcus aureus protein A affinity chromatography and
used these purified preparations for immunoblotting and immu-
nofluorescence analyses.
We obtained mouse monoclonal antibodies against WEEV
from ATCC (catalog No. VR-1251AF), mouse monoclonal
antibodies against NF68 and synaptophysin from Sigma (St.
Louis, MO), mouse monoclonal antibodies against GAPDH
from Santa Cruz Biotechnology (Santa Cruz, CA), and
neutralizing rabbit antisera against human IFNα and β from
R&D Systems (Minneapolis, MN). We obtained all secondary
antibodies for immunoblotting and immunofluorescence stain-
ing from Jackson Immunoresearch (West Grove, PA).
Type I IFNs, JAK inhibitor, and IFN-responsive reporter plasmid
We used recombinant human IFNα-A/D (Sigma), which is a
hybrid universal type I IFN that can substitute for all IFNα
subtypes, IFNβ, and IFNω (Sigma product literature) for all
experiments unless otherwise indicated. For select experiments
we used purified individual recombinant human type I IFNs,
including 12 IFNα isoforms, IFNβ, and IFNω (R&D Systems).
We obtained the cell-permeable JAK inhibitor Pyridone 6 from
Calbiochem (San Diego, CA) and the type I IFN-responsive
plasmid pISRE-SEAP and Quanti-Blue substrate from Invivo-
Gen (San Diego, CA).
Plaque assay
We used Vero cells and 12 well tissue culture plates for all
plaque assays. We incubated subconfluent Vero cell mono-
layers with culture supernatants serially diluted in sterile
phosphate buffered saline (100 mM sodium chloride, 50 mM
sodium phosphate, pH 7.4) with 0.2% bovine serum albumin
for 60 min at 37 °C, removed virus, and overlaid cells with
complete DMEM containing 0.6% SeaPlaque agarose (Cam-
brex, Rockland, ME) preheated to 50 °C. We allowed the
agarose to solidify at room temperature for 30 min, supple-
mented cultures with a 50% volume of complete DMEM, and
continued incubation at 37 °C for 36 to 48 h. After plaques
were visible we added formaldehyde to 9.25% for 30 min to
fix cells and inactivate infectious virus, gently removed the
media and agarose overlay, and stained monolayers with
0.1% crystal violet in 20% methanol. We air dried plates and
counted plaques in duplicate samples to calculate infectious
virus titers.
Immunofluorescence analysis
We cultured cells on either polyethyleneimine-coated or Lab-
Tek II CC2 eight-well chamber slides (Nalge Nunc, Rochester,
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(100 mM sodium chloride, 50 mM Tris, pH 7.2), and fixed
cells with 2% paraformaldehyde for 30min at room temperature.
We blocked slides with TBS containing 0.1% Tween 20 and 1%
goat serum for 1 h, incubated with primary antibodies diluted in
blocking buffer overnight, washed extensively in TBS with
0.1% Tween 20, and incubated with fluorescein- or Texas Red-
labeled secondary goat antibodies for 1 h.We stained nuclei with
0.5 μg/ml 4,6-diamidino-2-phenyindole (DAPI) and mounted
slides as previously described (Miller et al., 2001). We obtained
digital light and fluorescent images using a Zeiss Axiophot-2
microscope and CCD camera and prepared final images with
Adobe Photoshop software.
Immunoblot and Northern blot analyses
We prepared protein samples and performed immunoblot
analyses as previously described (Kampmueller and Miller,
2005) with the following modifications. We removed media
from adherent cell cultures, washed cells twice with TBS, and
lysed cells directly in tissue culture vessels with reducing SDS–
PAGE sample buffer (62.5 mM Tris [pH 6.8], 2% SDS, 5%
glycerol, 14.4 mM 2-mercaptoethanol, 0.02% bromophenol
blue). We used peroxidase-conjugated secondary antibodies and
developed immunoblots with an enhanced chemiluminescence
reagent solution containing 100 mM Tris (pH 8.5), 1.25 mM
luminol, 0.2 mM p-coumaric acid, and 0.001% hydrogen
peroxide.
We isolated total RNA with TRIzol reagent (Invitrogen,
Carlsbad, CA) and stored RNA samples at −80 °C until analysis.
We denatured samples in glyoxal buffer (Cambrex) prior to
separation in 1% agarose gels in 90mMTris–borate/2mMEDTA
buffer and subsequent transfer to ZetaProbe nylon membranes
(Bio-Rad, Hercules, CA). We prepared strand-specific 32P-
labeled riboprobes using an in vitro transcription system
(Promega, Madison, WI) with 32P-UTP according to the
manufacturer's instructions. We constructed the template plasmid
by inserting a PCR-generated fragment corresponding to viral
nucleotides 7551 to 7850 from pWE2000 into pGEM-4Z
(Promega). Primer sequences are available upon request. The
sequence used for probe generation encompassed the 5′ region of
the WEEV capsid protein coding sequence, and thus antisense
riboprobes efficiently detected both genomic and subgenomic
positive-sense viral RNA. We hybridized membranes with 32P-
labeled riboprobes in a solution containing 50mMphosphate (pH
6.8), 0.75 M sodium chloride, 75 mM sodium citrate, 1% SDS,
50% formamide, 5× Denhardt's solution, and 0.1 mg of salmon
sperm DNA/ml at 62 °C overnight, washed extensively with a
solution containing 0.1% SDS, 15 mM sodium chloride, and
1.5 M sodium citrate, and detected radioactive signals by
autoradiography with Blue Light AutoRad film (ISC BioExpress,
Kaysville, UT).
We obtained digital chemiluminescent and film images using
an Alpha Innotech Fluorchem 8900, quantitated band intensities
with AlphaEaseFC software, and prepared final images with
Adobe Photoshop software. When image cropping was nec-
essary, all panels were taken from the same exposure of the blotand all contrast adjustments to the initial image were done prior
to cropping.
Viability assays
We used MTT assays to determine cell viability after virus
infection. We incubated mock and infected cell cultures with
0.5 mg MTT/ml for 1 h at 37 °C, added an equal volume of stop
solution containing isopropanol with 10% Triton X-100 and
0.1 N hydrochloric acid to lyse cells, inactivate virus, and
solubilize formazan crystal, and measured the absorbance at
595 nm. We calculated cell viability as the percent A595 com-
pared to untreated or uninfected controls.
Statistical analyses
We used a two-tailed Student's t-test assuming unequal
variances for all statistical comparisons and considered a
p-valueb0.05 as statistically significant. We used log10-trans-
formed data for statistical comparisons of virus titers and a four-
parameter logistic sigmoidal regression analysis to calculate Hill
slope values. We present results that are representative of at least
three independent experiments, where quantitative data represent
the mean±SEM from those experiments.
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